Investor Relations

IR Home

Webcast ImageWebcast
Q2 2014 Vanda Pharmaceuticals Inc. Earnings Conference Call (Live)
08/07/14 at 10:00 a.m. ET
Q2 2014 Vanda Pharmaceuticals Inc. Earnings Conference Call
Thursday, August 7, 2014 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Stock Chart
VNDA (Common)
ExchangeNASDAQ (US Dollar)
Price$14.70
Change (%) Stock is Down 0.04 (0.27%)
Volume514,094
Data as of 07/31/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Corporate Profile

Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the science of developing new medicines and to use novel approaches to deliver these new medicines to patients... More >>

August 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-5-4-3-2-112
3456789
10111213141516
17181920212223
24252627282930
31515253545556

Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

Recent News
07/17/14
Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014
06/03/14
European Medicines Agency Accepts HETLIOZ™ (tasimelteon) Marketing Authorization Application for Non-24-Hour Sleep-Wake Disorder in the Totally Blind
06/02/14
HETLIOZ™ (tasimelteon) Data in Patients with Non-24-Hour Sleep-Wake Disorder to be presented at SLEEP 2014 meeting
More >>
Upcoming Events
Q2 2014 Vanda Pharmaceuticals Inc. Earnings Conference Call
Thursday, August 7, 2014 10:00 a.m. ET

More >>

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
  
Home | About Vanda | Product Pipeline | 24 | Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2007 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy